mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.02 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |